Skip to main content
Journal ArticleOPEN ACCESS

JAK kinase inhibitors for the treatment of acute lymphoblastic leukemia

Journal of Hematology and Oncology (2015) 8(1)
DOI: 10.1186/s13045-015-0192-7
21Citations
Citations of this article
62Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Recent studies of acute lymphoblastic leukemia have identified activating mutations in components of the interleukin-7 receptor complex (IL7R, JAK1, and JAK3). It will be of interest to investigate both JAK1 and JAK3 kinase inhibitors as targeted agents for these leukemias.

Author supplied keywords

Cite

CITATION STYLE

APA

Degryse, S., & Cools, J. (2015). JAK kinase inhibitors for the treatment of acute lymphoblastic leukemia. Journal of Hematology and Oncology, 8(1). https://doi.org/10.1186/s13045-015-0192-7

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free